|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 976.2 DKK | +1.06% |
|
-1.74% | +39.84% |
| Jul. 10 | US FDA declines to approve Novo Nordisk's weekly insulin | RE |
| Jul. 10 | US Senator Sanders optimistic Novo Nordisk can be pressured to cut Wegovy, Ozempic prices | RE |
July 10 (Reuters) - The U.S. Food and Drug Administration has declined to approve Novo Nordisk's weekly insulin in patients with diabetes, the Danish drugmaker said on Wednesday. (Reporting by Mariam Sunny in Bengaluru; Editing by Shailesh Kuber)
| 1st Jan change | Capi. | |
|---|---|---|
| +39.84% | 621B | |
| +61.22% | 840B | |
| -4.66% | 354B | |
| +16.77% | 319B | |
| +8.50% | 297B | |
| +13.94% | 237B | |
| +15.82% | 221B | |
| +1.84% | 220B | |
| +11.68% | 169B | |
| -1.53% | 157B |
NOVO NORDISK A/S 
